An experiment in the prevention of meningococcal meningitis in Nigeria.
In a population of approximately 100,000, 99% of the population was treated with at least one dose of sulphadimidine snuff and 94% with three or four doses over a period of two days. A dramatic reduction in the incidence of cerebrospinal meningitis followed immediately thereafter in the treated population, while the incidence continued to rise in adjacent comparable districts which had not been treated.
D006801:Humans; D015994:Incidence; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D009549:Nigeria
D022401:Meningococcal Vaccines
MENINGITIS, MENINGOCOCCIC/prevention and control